CCR5 is expressed on several cell types within the GBM TME and we have outlined compelling evidence for CCL5–CCR5 in invasive and metastatic behavior of many cancer types, known to participate in driving tumor progression, invasion, and metastasis. Here, CCL5 is linked to glioblastoma.